» Articles » PMID: 36560497

Vaccination Against Bacterial Mastitis in Sheep

Overview
Date 2022 Dec 23
PMID 36560497
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this review is to discuss the application of vaccination for the prevention of bacterial mastitis in ewes, performed within the frame of health management schemes in sheep flocks. Mastitis is a multi-faceted infection, caused most often by staphylococci; hence, special emphasis is given to staphylococcal mastitis, also given that most relevant studies refer to vaccinations against that infection. Studies regarding various vaccines have been performed; most studies refer to vaccination by using a vaccine making use of cell-free surface polysaccharides in various vehicles, bacterial unbound cells or bacterial cells embedded in their biofilm matrix. Vaccination against mastitis should be better performed during the final stage of pregnancy to allow protection of ewes from lambing and should be considered as one of many control measures for the prevention of the disease. The expected benefits of mastitis vaccination in sheep flocks include the following: (a) reduced incidence risk of clinical and subclinical mastitis, (b) reduced somatic cell counts, optimum chemical composition, absence of staphylococci in milk, (c) increased milk production, (d) reduced dissemination of mastitis-causing pathogens and (e) reduction of antibiotic use in flocks.

Citing Articles

An Investigation of Virulence Genes of in Autologous Vaccines Against Sheep Mastitis.

Sezzi E, Fanelli R, Gobbi D, Scandurra P, Mannucci V, Usai I Animals (Basel). 2024; 14(22).

PMID: 39595225 PMC: 11591023. DOI: 10.3390/ani14223172.


The Use of Machine Learning to Predict Prevalence of Subclinical Mastitis in Dairy Sheep Farms.

Kiouvrekis Y, Vasileiou N, Katsarou E, Lianou D, Michael C, Zikas S Animals (Basel). 2024; 14(16).

PMID: 39199829 PMC: 11350869. DOI: 10.3390/ani14162295.


Production of recombinant proteins including the B-cell epitopes of autolysin A of Staphylococcus aureus isolated from clinical sheep mastitis and their potential for vaccine development.

Azara E, Foddai A, Longheu C, Addis M, Tola S Vet Res Commun. 2023; 47(3):1665-1674.

PMID: 37074614 PMC: 10113713. DOI: 10.1007/s11259-023-10121-1.

References
1.
Hine B, Hunt P, Beasley A, Windon R, Glover S, Colditz I . Selective transport of IgE into ovine mammary secretions. Res Vet Sci. 2010; 89(2):184-90. DOI: 10.1016/j.rvsc.2010.02.010. View

2.
Watson D . Vaccination against experimental staphylococcal mastitis in ewes. Res Vet Sci. 1988; 45(1):16-21. View

3.
Azara E, Longheu C, Sanna G, Tola S . Biofilm formation and virulence factor analysis of Staphylococcus aureus isolates collected from ovine mastitis. J Appl Microbiol. 2017; 123(2):372-379. DOI: 10.1111/jam.13502. View

4.
Prenafeta A, March R, Foix A, Casals I, Costa L . Study of the humoral immunological response after vaccination with a Staphylococcus aureus biofilm-embedded bacterin in dairy cows: possible role of the exopolysaccharide specific antibody production in the protection from Staphylococcus aureus.... Vet Immunol Immunopathol. 2009; 134(3-4):208-17. DOI: 10.1016/j.vetimm.2009.09.020. View

5.
Craven N, Williams M . Defences of the bovine mammary gland against infection and prospects for their enhancement. Vet Immunol Immunopathol. 1985; 10(1):71-127. DOI: 10.1016/0165-2427(85)90039-x. View